SOLACI es la organización de referencia del intervencionismo cardiovascular latinoamericano.

Últimas Noticias

Coronary access after TAVI with fourth- and fifth-generation Evolut valves: the EPROMPT-CA study

Dr. Juan Manuel Pérez - 29 January, 2026 0

The expansion of transcatheter aortic valve implantation (TAVI) toward younger and lower-risk patients has increased the relevance of post-procedural coronary access. In this context,...

Morpheus Global Registry: Safety and efficacy of the long tapered BioMime™ Morph stent in complex coronary lesions

Dr. Juan Manuel Pérez - 28 January, 2026 0

Percutaneous coronary intervention in long coronary lesions continues to represent a technical and clinical challenge, in which the use of conventional cylindrical stents may...

TEER plus optimal medical therapy versus medical therapy alone in functional mitral regurgitation

Dr. Andrés Rodríguez - 26 January, 2026 0

Mitral regurgitation (MR) is a highly prevalent valvular heart disease that, in advanced stages and when left untreated, is associated with reduced quality of...

Accesos

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Términos de uso -Políticas de privacidad

Tag: post-TAVI coronary access

Coronary access after TAVI with fourth- and fifth-generation Evolut valves: the...

Últimas Noticias

Coronary access after TAVI with fourth- and fifth-generation Evolut valves: the EPROMPT-CA study

Morpheus Global Registry: Safety and efficacy of the long tapered BioMime™ Morph stent in complex coronary lesions

TEER plus optimal medical therapy versus medical therapy alone in functional mitral regurgitation

Noticias Institucionales

Watch Again: Cardiovascular Risk Factors in Women | SOLACI Technicians Webinar

Technical Training in Hemodynamics and Interventional Cardioangiology | SOLACI–CACI

SOLACI Webinar for Nurses and Technicians | Cardiovascular Risk Factors in Women

Accesos